🇺🇸 FDA
Patent

US 11202823

Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

granted A61KA61K2039/54A61K2039/543

Quick answer

US patent 11202823 (Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses) held by Northwestern University expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/54, A61K2039/543, A61K2039/55555, A61K2039/55588